Literature DB >> 6848391

Prolactin in the evaluation of luteal phase in infertility.

J A Vanrell, J Balasch.   

Abstract

Hyperprolactinemia was detected in 15 of 130 infertile patients (11.5%) with regular menstrual cycles and no galactorrhea who underwent luteal phase evaluation by basal body temperature (BBT), plasma estradiol (E2), and progesterone (P) determination, and endometrial biopsy (repeated in a later cycle when the first was defective). Luteal phase length and plasma levels of P and E2 were similar in the hyperprolactinemic and normoprolactinemic patients. Moreover, a significantly higher incidence of inadequate luteal phase, histologically documented, was found in the normoprolactinemic group. It is concluded that the usefulness of plasma prolactin (PRL) determination in the evaluation of luteal function in infertility is scanty and that most histologically documented cases of luteal phase defects occur with euprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848391     DOI: 10.1016/s0015-0282(16)46753-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volume.

Authors:  Tomoko Inoue; Shu Hashimoto; Hideyuki Iwahata; Keijiro Ito; Yoshiharu Nakaoka; Yoshiharu Morimoto
Journal:  Reprod Med Biol       Date:  2014-11-11

Review 2.  Treatment of Prolactinoma.

Authors:  Warrick J Inder; Christina Jang
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.